Reunión presencial

GO NORTE INTERNATIONAL GU DEBATES

27 octubre 2022

- 28 octubre 2022

Go Norte Grupo oncológico twentyfour bullets verdigris
PROGRAMA 27 y 28 octubre 2022
DAY 1. Thursday OCT 27TH
15:30 h – OPENING

Dr. Duran

BLADDER CANCER: TOPICS FOR DISCUSSION
15:40-16:30h TRIMODALITY TREATMENT AS AN ALTERNATIVE TO RADICAL CYSTECTOMY IN MIBC

(i) TMT: State of the art.
(ii) FAVOR
(iii) CONS:
(iv) Discussion

16:35-17:25 PERIOPERATIVE TREATMENT IN MIBC

(v) STATE OF THE ART.
(vi) CHEMO AS THE PREFERED PERIOP STRATEGY
(vii) IO BASED STRATEGIES AS THE WINNER
(viii) DISCUSSION

COFFE BREAK. 17:25-17:50 H
The patient’s voice
17:50-18:40 FIRST LINE TREATMENT OF METASTATIC UROTHELIAL CARCINOMA

(i) STATE OF THE ART
(ii) CHEMO + IO MAINTENANCE FOR ALL PATIENTS: NO ROLE FOR PATIENT SELECTION
(iii) PATIENT SELECTION MATTERS
(iv) DISCUSSION

18:45-19:35 BLADDER CANCER: TREATMENT BEYOND PROGRESSION TO CPI

(i) STATE OF THE ART
(ii) PRO TARGETED THERAPY
(iii) PRO ADCs
(iv) DISCUSSION

19.35-20.15 BLADDER CANCER: THE SCIENCE CORNER

Ongoing projects and opportunities for collaboration
EBANO; UROGALLO; PROBLADDER

THE INDUSTRY CORNER
20:15 CLOSING
DINNER ATTENDEES
DAY 2. Friday OCT 28TH
8:30 h – OPENING

Dr. Duran

RENAL CELL CANCER: TOPICS FOR DISCUSSION
8:35-9:25 RENAL CELL CANCER: PERIOPERATIVE TREATMENT LOCALIZED RCC

(i) STATE OF THE ART.
(ii) Pro Adjuvant treatment as per trial population
(iii) Pro patient selection when applying adjuvant treatment
(iv) Discussion

9:25-10:15 1 st LINE TREATMENT mRCC

(i) STATE OF THE ART
(ii) THE DOUBLETS ARE MORE THAN ENOUGH
(iii) TOWARDS THE TRIPLE THERAPY IN mRCC
(iv) DISCUSSION

10:15-10:45 H RENAL CELL CANCER: THE SCIENCE CORNER

ART PROJECT. RENO. OTHERS

10.45-11.15 COFFE BREAK
PROSTATE CANCER: TOPICS FOR DISCUSSION
11:20-12:10h CHALLENGES AROUND mHSPC

(i) STATE OF THE ART.
(ii) TRIPLE THERAPY: FOR WHOM
(iii) DOUBLETS: ANY WINNER?
(iv) DISCUSSION

12:15-13:30 H TARGETED THERAPY IN PROSTATE CANCER: MYTH OR REALITY

(i) DNA DAMAGED REPAIR GENES AS A VALID TARGET
(ii) PTEN AS A TARGET
(iii) PSMA AS A TARGET
(iv) THE IMMUNE SYSTEM AS A TARGET
(v) DISCUSSION

13:30-14:00 PROSTATE CANCER: THE SCIENCE CORNER

IRONMAN

CLOSING REMARKS
Confirmed speakers:

David Buscher, Daniel Castellano, Mario Domínguez, Albert Font, Jesús García-Donas, Enrique González-Billalabeitia, Enrique Grande, Roberto Iacovelli, David Lorente, Pablo Maroto, José Luis Pérez Gracia, Josep Maria Piulats, Giuseppe Procopio, Javier Puente, Juan Francisco Rodríguez Moreno, Alejo Rodriguez Vida, Bertrandt Tombal.

#

Patrocinadores:

Go Norte Grupo oncológico Astellas
Logotipo Bristol Myers Squibb
logos de merck y pfizer
Logo MSD
Hazte socio de GO NORTE Grupo Oncológico

Dra. Nuria Laínez
Vicepresidenta GO NORTE

Hazte socio, hazte socia

En la lucha contra los tumores genitourinarios todos y todas somos necesarios.

Hazte socio de GO NORTE Grupo Oncológico

Dra. Nuria Lainez
Vicepresidenta GO NORTE

Ir arriba